特里普坦
冠状动脉
医学
背景(考古学)
心脏病学
内科学
偏头痛
动脉
生物
古生物学
作者
Antoinette MaassenVanDenBrink,Pramod R. Saxena
出处
期刊:Headache
[Wiley]
日期:2004-05-01
卷期号:44 (s1)
被引量:45
标识
DOI:10.1111/j.1526-4610.2004.04104.x
摘要
This article reviews the in vitro pharmacology of the triptans in human isolated coronary arteries. As expected, based on their similar pharmacologic profiles, the triptans cannot be easily differentiated with respect to effects at human isolated coronary arteries. Furthermore, the data show that at therapeutically relevant concentrations, triptans have little potential to cause clinically significant constriction of nondiseased coronary arteries. These data, considered in the context of clinical findings reviewed elsewhere in this supplement, support the conclusion that, while all triptans have the potential to produce small contractions of human isolated coronary arteries, their craniovascular selectivity, when used at therapeutic doses, renders them unlikely to cause serious adverse coronary events in patients with healthy coronary arteries.
科研通智能强力驱动
Strongly Powered by AbleSci AI